Over the past few years, sleep disorders have emerged as a key public health issue affecting the mental and physical well being of the person. More than 80 types of sleeping disorders are identified, and among them, Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, Circadian Rhythm Disorders are the most common sleeping disorders that affect a significant proportion of the population worldwide.
If remains untreated the sleeping disorder may lead to many health complications such as hypertension, type 2 diabetes, stroke, cardiovascular disease, obesity, heart attack, depression, mood change, anxiety disorders and many others. As of now, many therapeutics options are available for Sleep Disorders. However, to tackle the increasing prevalence and to fulfil the unmet need in the sleep disorders market, companies such as Apnimed, Avadel Pharmaceuticals, Bayer Pharmaceuticals, Eisai US, Evotec, Idorsia Pharmaceuticals, Minerva Neurosciences and others are diligently involved in the therapeutics development.
For more details, visit: Sleep Disorders Causes, Diagnosis, and Treatments